Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Sir Richard Sykes Appointed Chair of Vaccine Taskforce
Sir Richard will use his extensive experience in biotechnology and pharmaceuticals to lead the significant […]
Dr. Paul Burton to Join Moderna as Chief Medical Officer
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today […]
Sectra Speeds Up Clinical Use of AI -- Digital Pathology Apps Now Available in Marketplace
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) expands its AI marketplace with digital pathology. […]
NHS Digital Terminology Server Goes Live
NHS Digital’s Terminology Server, a solution which enables healthcare IT systems to speak the same […]
Introducing Andros: The Technology Company Revolutionizing Healthcare via One, Interconnected Data Network
andros, the healthcare technology company that is radically changing healthcare industry operations by connecting payer […]
Pilloxa Launches the First Plug-and-play Platform to Create Apps to Connect Patients with Pharma and HCPs
Digital health company Pilloxa today announced the launch of their new product offering, a cloud-hosted […]
Startup Hertility Health Raises £4.2M in Seed Funding to Help Reduce Diagnosis Time of Most Common Reproductive Issues
Hertility Health, the new women’s health start-up revolutionising the world of hormone and reproductive health, […]
Hephaï Files Software Patent for its Digital Education Platform Designed to Improve Patient Inhaler Use
Hephaï, a French start-up developing an AI-based digital education platform, today announces that it has […]
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial
Novavax, Inc. (Nasdaq: NVAX), today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% […]
TailorMed Fuels Further Growth with a $20 Million Financing, Led by Providence Ventures
TailorMed Medical Ltd., a leading patient financial navigation technology company that helps healthcare patients remove […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more